CHRISTOPHER JOHN YARNOLD,FELIX FUNK,FRANZ DÜRRENBERGER,JULIA MARIE BAINBRIDGE,MARK PETER RIDGILL,MARK SLACK,PETER OTTO GEISSER,STEFAN JAEGER,STEPHEN MARTIN COURTNEY,SUSANNA BURCKHARDT,TARA DAVENPORT,V
申请号：
BR112012008109
公开号：
BR112012008109A2
申请日:
2010.08.31
申请国别(地区):
BR
年份:
2019
代理人:
摘要：
The present invention relates to new hepcidin antagonists, pharmaceutical compositions containing them and the use thereof as a drug, in particular for the treatment of iron metabolism disorders such as, in particular, iron deficiency diseases and anaemia, in particular anaemia associated with chronic inflammatory disease (ACD: anaemia of chronic disease and AI: anaemia of inflammation).
